Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms

American Journal of Psychiatry

Volumn 160, Issue 9, 2003, Pages 1699-1701

  Sekine, Yoshimoto ^b   Minabe, Yoshio ^a   Ouchi, Yasuomi ^b   Takei, Nori ^b   Iyo, Masaomi ^b   Nakamura, Kazuhiko ^b   Suzuki, Katsuaki ^b   Tsukada, Hideo ^b   Okada, Hiroyuki ^b   Yoshikawa, Etsuji ^b   Futatsubashi, Masami ^b   Mori, Norio ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBON 11; DOPAMINE TRANSPORTER; METHAMPHETAMINE; (1R (EXO,EXO)) 3 (4 FLUOROPHENYL) 8 METHYL 8 AZABICYCLO(3.2.1)OCTANE 2 CARBOXYLIC ACID, METHYL ESTER; (1R-(EXO,EXO))-3-(4-FLUOROPHENYL)-8-METHYL-8- AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, METHYL ESTER; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE SEVERITY; DRUG USE; HUMAN; MALE; MENTAL DISEASE; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE; SYMPTOM; CHEMISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG ABUSE; FRONTAL LOBE; METABOLISM; PSYCHOSIS; SCINTISCANNING;

ADULT; AMPHETAMINE-RELATED DISORDERS; AMYGDALA; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FRONTAL LOBE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; PSYCHOSES, SUBSTANCE-INDUCED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0642343875     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.9.1699     Document Type: Article

References (9)

1. 11C]WIN-35,428. J Neurosci 1998; 18:8417-8422
2. Volkow ND, Chang L, Wang G-J, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding Y-S, Logan J, Wong C, Miller EN: Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377-382
3. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N: Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158:1206-1214
4. 2 receptors in methamphetamine abusers: association with metabolism in the orbilofrontal cortex. Am J Psychiatry 2001; 158:2015-2021
5. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA: Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 2002; 26:53-63
6. Holland PC, Gallagher M: Amygdala circuitry in attentional and representational processes. Trends Cogn Sci 1999; 3:65-73
7. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M: Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999; 45:601-610
8. Wang GJ, Volkow ND, Roque CT, Cestaro VL, Hitzemann RJ, Cantos EL, Levy AV, Dhawan AP: Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 1993; 186:59-65
9. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J: Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 2001; 21:9414-9418